Previous Article | Next Article ![]()
Journal of Clinical Microbiology, January 1999, p. 215-217, Vol. 37, No. 1
National Centre for Streptococcus, Edmonton,
Canada1;
Departamento de Laboratorios de
Salud, Ministerio de Salud Pública, Montevideo,
Uruguay2;
Instituto Nacional de Salud
Pública, Cuernavaca, Mexico3;
Instituto Nacional de Salud, Bogotá,
Colombia4;
Instituto de Salud
Pública, Santiago, Chile5;
Instituto Adolfo Lutz, São Paulo,
Brazil6; and
Instituto Nacional de
Microbiología Dr. Carlos Malbran, Buenos Aires,
Argentina7
Received 7 July 1998/Returned for modification 29 July
1998/Accepted 29 September 1998
An international, multicenter study compared
trimethoprim-sulfamethoxazole MICs for 743 Streptococcus
pneumoniae isolates (107 to 244 isolates per country) by E test,
using Mueller-Hinton agar supplemented with 5% defibrinated horse
blood or 5% defibrinated sheep blood, with MICs determined by the
National Committee for Clinical Laboratory Standards broth
microdilution reference method. Agreement within 1 log2
dilution and minor error rates were 69.3 and 15.5%, respectively, on
sheep blood-supplemented agar and 76.9 and 13.6%, respectively, with
horse blood as the supplement. Significant interlaboratory variability
was observed. E test may not be a reliable method for determining the
resistance of pneumococci to trimethoprim-sulfamethoxazole.
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Determination of Trimethoprim-Sulfamethoxazole
Resistance in Streptococcus pneumoniae by Using the E Test
with Mueller-Hinton Agar Supplemented with Sheep or Horse Blood
May Be Unreliable
*
Corresponding author. Mailing address: National Centre
for Streptococcus, Rm. 1B3.26 WMC, University of Alberta Hospital, 8440-112 St., Edmonton, Alberta, Canada T6G 2J2. Phone: (403) 492-8977. Fax: (403) 492-8984. E-mail: ml{at}bugs.uah.ualberta.ca.
Members of The Pneumococcal Study Group are J. Weekes, L. McKercher, B. Forwick, and T. Ng, from National Centre for
Streptococcus, Edmonton, Canada; M. Hortal, from Departmento de
Laboratorios de Salud, Ministerio de Salud Pública, Montevideo,
Uruguay; M. N. Carnalla, M. E. Velazquez, Y. Jimenez,
P. Cárdenas, A. Peréz, F. J. López-Antunano,
and F. Solórzano, from Instituto Nacional de Salud Pública,
Cuernavaca, Mexico; S. T. Casagrande and S. C. G. Almeida, from Instituto Adolfo Lutz, São Paulo,
Brazil; and A. Corso, from Instituto Nacional de Microbiología
Dr. Carlos Malbran, Buenos Aires, Argentina.
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|